Tax Policy: Pharmaceutical Industry's Use of the Research Tax Credit
GGD-94-139
Published: May 13, 1994. Publicly Released: Jun 15, 1994.
Skip to Highlights
Highlights
Pursuant to a congressional request, GAO reviewed the major tax benefits used by the pharmaceutical industry, focusing on: (1) the characteristics of the companies claiming research tax credits; and (2) whether Internal Revenue Service (IRS) tax administration efforts adequately ensure that pharmaceutical companies comply with tax credit legislation.
Full Report
Office of Public Affairs
Topics
BiotechnologyCorporationsInvestmentsPharmaceutical industryPharmacological researchResearch and developmentTax administrationTax creditTax lawTax return auditsTax shelters